| Welcome to Viventia Biotechnologies Inc. |
| Viventia Biotechnologies Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of advanced monoclonal antibody products designed to offer safer, more beneficial therapies for those who suffer from cancer. Viventia is employing its novel monoclonal antibody discovery and development platforms to discover, validate and advance a portfolio of new antibody products based on proprietary oncology drug targets. |
